289 related articles for article (PubMed ID: 26248686)
21. Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity.
Vral A; Willems P; Claes K; Poppe B; Perletti G; Thierens H
Mol Med Rep; 2011; 4(5):901-12. PubMed ID: 21725594
[TBL] [Abstract][Full Text] [Related]
22. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
Hamdi Y; Soucy P; Kuchenbaeker KB; Pastinen T; Droit A; Lemaçon A; Adlard J; Aittomäki K; Andrulis IL; Arason A; Arnold N; Arun BK; Azzollini J; Bane A; Barjhoux L; Barrowdale D; Benitez J; Berthet P; Blok MJ; Bobolis K; Bonadona V; Bonanni B; Bradbury AR; Brewer C; Buecher B; Buys SS; Caligo MA; Chiquette J; Chung WK; Claes KB; Daly MB; Damiola F; Davidson R; De la Hoya M; De Leeneer K; Diez O; Ding YC; Dolcetti R; Domchek SM; Dorfling CM; Eccles D; Eeles R; Einbeigi Z; Ejlertsen B; ; Engel C; Gareth Evans D; Feliubadalo L; Foretova L; Fostira F; Foulkes WD; Fountzilas G; Friedman E; Frost D; Ganschow P; Ganz PA; Garber J; Gayther SA; ; Gerdes AM; Glendon G; Godwin AK; Goldgar DE; Greene MH; Gronwald J; Hahnen E; Hamann U; Hansen TV; Hart S; Hays JL; ; Hogervorst FB; Hulick PJ; Imyanitov EN; Isaacs C; Izatt L; Jakubowska A; James P; Janavicius R; Jensen UB; John EM; Joseph V; Just W; Kaczmarek K; Karlan BY; ; Kets CM; Kirk J; Kriege M; Laitman Y; Laurent M; Lazaro C; Leslie G; Lester J; Lesueur F; Liljegren A; Loman N; Loud JT; Manoukian S; Mariani M; Mazoyer S; McGuffog L; Meijers-Heijboer HE; Meindl A; Miller A; Montagna M; Mulligan AM; Nathanson KL; Neuhausen SL; Nevanlinna H; Nussbaum RL; Olah E; Olopade OI; Ong KR; Oosterwijk JC; Osorio A; Papi L; Park SK; Pedersen IS; Peissel B; Segura PP; Peterlongo P; Phelan CM; Radice P; Rantala J; Rappaport-Fuerhauser C; Rennert G; Richardson A; Robson M; Rodriguez GC; Rookus MA; Schmutzler RK; Sevenet N; Shah PD; Singer CF; Slavin TP; Snape K; Sokolowska J; Sønderstrup IM; Southey M; Spurdle AB; Stadler Z; Stoppa-Lyonnet D; Sukiennicki G; Sutter C; Tan Y; Tea MK; Teixeira MR; Teulé A; Teo SH; Terry MB; Thomassen M; Tihomirova L; Tischkowitz M; Tognazzo S; Toland AE; Tung N; van den Ouweland AM; van der Luijt RB; van Engelen K; van Rensburg EJ; Varon-Mateeva R; Wappenschmidt B; Wijnen JT; Rebbeck T; Chenevix-Trench G; Offit K; Couch FJ; Nord S; Easton DF; Antoniou AC; Simard J
Breast Cancer Res Treat; 2017 Jan; 161(1):117-134. PubMed ID: 27796716
[TBL] [Abstract][Full Text] [Related]
23. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.
Kadouri L; Easton DF; Edwards S; Hubert A; Kote-Jarai Z; Glaser B; Durocher F; Abeliovich D; Peretz T; Eeles RA
Br J Cancer; 2001 Jul; 85(1):36-40. PubMed ID: 11437399
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.
Heemskerk-Gerritsen BA; Seynaeve C; van Asperen CJ; Ausems MG; Collée JM; van Doorn HC; Gomez Garcia EB; Kets CM; van Leeuwen FE; Meijers-Heijboer HE; Mourits MJ; van Os TA; Vasen HF; Verhoef S; Rookus MA; Hooning MJ;
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25788320
[TBL] [Abstract][Full Text] [Related]
25. Single Nucleotide Polymorphisms within the 8Q24 Region are Not Associated with the Risk of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Panic N; Larghi A; Amore R; Pastorino R; Bulajic M; Costamagna G; Boccia S
J Gastrointestin Liver Dis; 2016 Sep; 25(3):311-5. PubMed ID: 27689194
[TBL] [Abstract][Full Text] [Related]
26. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
27. Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.
Deb S; Jene N; ; Fox SB
BMC Cancer; 2012 Nov; 12():510. PubMed ID: 23146383
[TBL] [Abstract][Full Text] [Related]
28. Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy.
Ottini L; Rizzolo P; Zanna I; Silvestri V; Saieva C; Falchetti M; Masala G; Navazio AS; Capalbo C; Bianchi S; Manoukian S; Barile M; Peterlongo P; Caligo MA; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Cini G; Montagna M; Radice P; Palli D
Breast Cancer Res Treat; 2014 Dec; 148(3):623-8. PubMed ID: 25385181
[TBL] [Abstract][Full Text] [Related]
29. A replication study examining association of rs6983267, rs10090154, and rs1447295 common single nucleotide polymorphisms in 8q24 region with prostate cancer in Siberians.
Oskina NA; Boyarskikh UA; Lazarev AF; Petrova VD; Ganov DI; Tonacheva OG; Lifshits GI; Filipenko ML
Urol Oncol; 2014 Jan; 32(1):37.e7-12. PubMed ID: 23628314
[TBL] [Abstract][Full Text] [Related]
30. BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases.
Falchetti M; Lupi R; Rizzolo P; Ceccarelli K; Zanna I; Calò V; Tommasi S; Masala G; Paradiso A; Gulino A; Giannini G; Russo A; Palli D; Ottini L
Breast Cancer Res Treat; 2008 Jul; 110(1):161-7. PubMed ID: 17661168
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.
Abulí A; Bessa X; González JR; Ruiz-Ponte C; Cáceres A; Muñoz J; Gonzalo V; Balaguer F; Fernández-Rozadilla C; González D; de Castro L; Clofent J; Bujanda L; Cubiella J; Reñé JM; Morillas JD; Lanas A; Rigau J; García AM; Latorre M; Saló J; Fernández Bañares F; Argüello L; Peña E; Vilella A; Riestra S; Carreño R; Paya A; Alenda C; Xicola RM; Doyle BJ; Jover R; Llor X; Carracedo A; Castells A; Castellví-Bel S; Andreu M;
Gastroenterology; 2010 Sep; 139(3):788-96, 796.e1-6. PubMed ID: 20638935
[TBL] [Abstract][Full Text] [Related]
32. rs15869 at miRNA binding site in BRCA2 is associated with breast cancer susceptibility.
Cao J; Luo C; Yan R; Peng R; Wang K; Wang P; Ye H; Song C
Med Oncol; 2016 Dec; 33(12):135. PubMed ID: 27807724
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of Italy.
Miolo G; Puppa LD; Santarosa M; De Giacomi C; Veronesi A; Bidoli E; Tibiletti MG; Viel A; Dolcetti R
BMC Cancer; 2006 Jun; 6():156. PubMed ID: 16764716
[TBL] [Abstract][Full Text] [Related]
34. Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.
Surowy HM; Sutter C; Mittnacht M; Klaes R; Schaefer D; Evers C; Burgemeister AL; Goehringer C; Dikow N; Heil J; Golatta M; Schott S; Schneeweiss A; Bugert P; Sohn C; Bartram CR; Burwinkel B
Breast Cancer Res Treat; 2014 Jun; 145(2):451-60. PubMed ID: 24728577
[TBL] [Abstract][Full Text] [Related]
35. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
Figueroa JD; Garcia-Closas M; Humphreys M; Platte R; Hopper JL; Southey MC; Apicella C; Hammet F; Schmidt MK; Broeks A; Tollenaar RA; Van't Veer LJ; Fasching PA; Beckmann MW; Ekici AB; Strick R; Peto J; dos Santos Silva I; Fletcher O; Johnson N; Sawyer E; Tomlinson I; Kerin M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Bojesen S; Flyger H; Nordestgaard BG; Benítez J; Milne RL; Ignacio Arias J; Zamora MP; Brenner H; Müller H; Arndt V; Rahman N; Turnbull C; Seal S; Renwick A; Brauch H; Justenhoven C; Brüning T; ; Chang-Claude J; Hein R; Wang-Gohrke S; Dörk T; Schürmann P; Bremer M; Hillemanns P; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Bogdanova N; Antonenkova N; Rogov YI; Karstens JH; Bermisheva M; Prokofieva D; Gantcev SH; Khusnutdinova E; Lindblom A; Margolin S; Chenevix-Trench G; Beesley J; Chen X; ; Mannermaa A; Kosma VM; Soini Y; Kataja V; Lambrechts D; Yesilyurt BT; Chrisiaens MR; Peeters S; Radice P; Peterlongo P; Manoukian S; Barile M; Couch F; Lee AM; Diasio R; Wang X; Giles GG; Severi G; Baglietto L; Maclean C; Offit K; Robson M; Joseph V; Gaudet M; John EM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis I; Knight JA; Mulligan AM; O'Malley FP; Brinton LA; Sherman ME; Lissowska J; Chanock SJ; Hooning M; Martens JW; van den Ouweland AM; Collée JM; Hall P; Czene K; Cox A; Brock IW; Reed MW; Cross SS; Pharoah P; Dunning AM; Kang D; Yoo KY; Noh DY; Ahn SH; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Shen CY; Ding SL; Hsu HM; Yu JC; Anton-Culver H; Ziogas A; Ashworth A; Swerdlow A; Jones M; Orr N; Trentham-Dietz A; Egan K; Newcomb P; Titus-Ernstoff L; Easton D; Spurdle AB
Hum Mol Genet; 2011 Dec; 20(23):4693-706. PubMed ID: 21852249
[TBL] [Abstract][Full Text] [Related]
36. Low penetrance breast cancer predisposition SNPs are site specific.
Mcinerney N; Colleran G; Rowan A; Walther A; Barclay E; Spain S; Jones AM; Tuohy S; Curran C; Miller N; Kerin M; Tomlinson I; Sawyer E
Breast Cancer Res Treat; 2009 Sep; 117(1):151-9. PubMed ID: 19005751
[TBL] [Abstract][Full Text] [Related]
37. Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province.
Jiang Y; Han J; Liu J; Zhang G; Wang L; Liu F; Zhang X; Zhao Y; Pang D
Breast Cancer Res Treat; 2011 Jul; 128(1):251-7. PubMed ID: 21197568
[TBL] [Abstract][Full Text] [Related]
38. Are VNTRs co-localizing with breast cancer-associated SNPs?
Leclerc M; Neuhausen SL; Schayek H; Laitman Y; Antonis AC; Friedman E
Breast Cancer Res Treat; 2018 Feb; 168(1):277-281. PubMed ID: 29168065
[TBL] [Abstract][Full Text] [Related]
39. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
[TBL] [Abstract][Full Text] [Related]
40. Polymorphic repeat length in the AIB1 gene and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis of observational studies.
Bianco A; Quaresima B; Pileggi C; Faniello MC; De Lorenzo C; Costanzo F; Pavia M
PLoS One; 2013; 8(3):e57781. PubMed ID: 23483928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
